FDA Inspection
Hetero Labs Limited - Unit IIIHetero Labs Limited - Unit III – FDA Inspection, Mar 23, 2018
Record Details
This FDA Inspection record concerns Hetero Labs Limited - Unit III, with an inspection on March 23, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Rita K. Vick (Issuing Officer)
View Company Profile
ID · cdeffc5b-480c-4fe1-a8c6-e0e93c6be909
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1045339
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.194(c)Testing and standardization of standards et. al.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hetero Labs Limited - Unit III
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| October 26, 2016 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| July 31, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hetero Labs Limited - Unit III
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.